Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05815615
Other study ID # RK2020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date December 31, 2022

Study information

Verified date April 2023
Source Université Catholique de Louvain
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Only very few studies have prospectively looked at the effect of repeated intensive plasma donation. In collaboration with the Rode Kruis Vlaanderen, we have recently found that repeated whole blood donation with a 3-month interval in between induced a drop in markers for iron status, which worsened with the number of donations. The repetition effect of the donations, whether whole blood or plasma, can be different from the effects measured after one single donation. It is therefore critical to test and document this repetitive effect to build trustable and valid guidelines concerning repetitive plasma donation.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 50 Years
Eligibility Inclusion criteria: - male, - age between 18-50 years - BMI between 20-28 kg/m2 - aptitude to perform maximal physical efforts assessed by the physical activity readiness questionnaire (PAR-Q) Exclusion criteria: - The specific exclusion criteria of the Rode Kruis Vlaanderen for blood donation will not be systematically applied to the present study to increase the pool of recruitment. - In case the subjects do not comply with the criteria of the Rode Kruis Vlaanderen, their plasma donations will be thrown away. - In case the subjects comply, their plasma donations will be handled as usually. - The criteria will be assessed before each plasma donation by a questionnaire as usually done in the Center of the Rode Kruis.

Study Design


Intervention

Device:
Plasmapheresis
Plasma donation at different frequencies

Locations

Country Name City State
Belgium UCLouvain Louvain-la-Neuve Brabant Wallon

Sponsors (1)

Lead Sponsor Collaborator
Université Catholique de Louvain

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Other Blood markers red blood cells in 10^6/mm^3 3 months
Other Blood markers haemoglobin in g/dl 3 months
Other Blood markers haematocrit in % 3 months
Other Blood markers iron in ug/dl 3 months
Other Blood markers ferritin in ug/l 3 months
Other Blood markers glycated haemoglobin in % 3 months
Other Blood markers creatine kinase in U/l 3 months
Other Blood markers total cholesterol in mg/dl 3 months
Other Blood markers reticulocytes in % 3 months
Other Weight in kg 3 months
Primary Blood markers albumin in g/l 3 months
Primary Blood markers Immunoglobulins G, M and A in G/l 3 months
Primary Sport performance VO2max in mlO2/kg/min determined breath-by-breath on a cycloergometer 3 months
Primary Sport performance maximal force of the quadriceps in kg measured on a leg extension machine 3 months
Secondary Body composition fat mass in kg measured by DEXA 3 months
Secondary Body composition lean mass in kg measured by DEXA 3 months
Secondary Blood pressure systolic and diastolic blood pressure in mmHG 3 months
See also
  Status Clinical Trial Phase
Completed NCT03995979 - Inflammation and Protein Restriction N/A
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT05529693 - Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population N/A
Recruiting NCT05415397 - Treating Immuno-metabolic Depression With Anti-inflammatory Drugs Phase 3
Recruiting NCT05670301 - Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases N/A
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. N/A
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Not yet recruiting NCT06134076 - Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota N/A
Not yet recruiting NCT06422494 - The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II N/A